
Maha Katabi
General Partner · Sofinnova Investments
General PartnerMenlo Park, CA
Maha Katabi, PhD, CFA, is a General Partner at Sofinnova Investments who has served on the board of Vera Therapeutics since 2020. Aggregator coverage describes her focus as clinical-stage single-asset radiopharmaceutical and targeted oncology companies and crossover public/private biotech investing.
Board seats
11 current
· PUBLIC SOURCES
Credited hits
3
· PUBLIC SOURCES
Midas years
LAST CHECKED NOV 2026
Founder rating
LAST CHECKED NOV 2026
Maintained from public sources. Not claimed. If you're Maha Katabi, you can claim this profile.
Claim this profileHow claiming worksClaiming verifies identity and affiliation. It does not permit editing reviews, scores, or cited facts.
Track record
- Aiolos Bioacquired
Named among Katabi's exits; Aiolos Bio was acquired by GSK, per Wikipedia's Sofinnova summary.
Source: en.wikipedia.org
- RayzeBioacquired
Named among Katabi's exits; RayzeBio was acquired by Bristol Myers Squibb, per Wikipedia's Sofinnova summary.
Source: en.wikipedia.org
- Amplyxacquired
Named among Katabi's exits; Amplyx was acquired by Pfizer, per Wikipedia's Sofinnova summary.
Source: en.wikipedia.org
Board seats
Current board seats · 1
- Vera TherapeuticsSource: en.wikipedia.org
Success signals
Forbes Midas List
No public record
Not listed.
Reputation
No reputation score — basis not established for this investor.
No reputation sources on file yet.
Suggest a sourceContact
Published sources only
Published contact details collected from public sources. Not a referral, and not an introduction.
Published contact
- Website
- www.sofinnova.com
Published sources only
GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.
Claimed profiles can replace or remove contact details.
What founders say
Founder-submitted · Verified identity and relationship
No founder reviews yet
Be the first founder to share your experience with Maha Katabi. Reviews come from founders whose identity and relationship have been verified.
Write the first reviewFirm-level reviews are not attributed to Maha Katabi.
Methodology
This profile carries no tier: tier belongs to the firm and is shown only via the linked firm name — never inherited onto a person.
Credited deals, board seats, Midas years and reputation links are carried per investor in the catalog, each item with the public source it was credited from, linked from the sections above. Fields with no sourced record render their honest null states, and every published field traces to the catalog record listed below. Review dimension scores appear only at three or more reviews.
Corrections with a source: Suggest a correction.
Source record 1
- [1]
DATABASE · GlassVC catalog — Catalog record for Maha Katabi — provenance: GlassVC extended catalog, November 2026
↩ cites: Title · Firm · Type · Bio · Location · Focus · Credited deals · Board seats
EVERY FIGURE ON THIS PAGE IS TRACEABLE TO THE CATALOG RECORD ABOVE · LAST CHECKED NOV 2026
